First National Corp’s GSK GSK Stock Holding History

First National Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-1,312	Closed	-$69K	–	250
2019 Q1	$69K	Hold	1,312	–	–	0.03%	200
2018 Q4	$63K	Buy	+1,312	New	+$64.6K	0.03%	209

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

First National Corp's GSK Position: Q2 2019 in Review

First National Corp sold out of GSK (GSK) in Q2 2019, closing a stake of 1,312 shares — an estimated $69K sold.

First National Corp first reported a position in GSK in Q4 2018 and held it in 2 quarters. The position peaked at $69K in Q1 2019. 804 funds tracked by Wall St. Rank hold GSK as of Q2 2019.

First National Corp reported no remaining GSK position as of Q2 2019 after selling out during the quarter.
First National Corp sold 1,312 GSK shares in Q2 2019, an estimated $69K.
First National Corp first reported a position in GSK in Q4 2018 and held it in 2 quarters.
First National Corp's GSK position peaked at $69K in Q1 2019.
804 funds tracked by Wall St. Rank held GSK as of Q2 2019.

Based on First National Corp's 13F filing for Q2 2019, filed 30 Jul 2019.